On the actual clinical trial research being done on cannabis now, Prof. Dedi Meiri, “We are starting with para-clinical. We first screen on cell lines from tumors, many types of cannabis. We have an ability to screen a lot. We have over than 600 different types of cannabis, and every one of them have hundreds of different compounds, and we know, in my lab, to identify all of them, to purify them if we need. So, we’re starting with very wide screen.”


Read the full transcript:

Become a member to access to webinars, quarterly reports, contributor columns, shows, excerpts, and complete podcast transcripts

Become a Member

Already a member? Login here.